Page last updated: 2024-12-06

tetrahydropyrimidinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tetrahydropyrimidinones are a class of heterocyclic compounds with a wide range of biological activities, including anti-cancer, anti-inflammatory, and antimicrobial properties. They are often synthesized through a variety of methods, including the Biginelli reaction, which involves the condensation of an aldehyde, a β-ketoester, and urea. Their importance stems from their diverse pharmacological profiles and potential applications in drug discovery. Research focuses on exploring their structure-activity relationships, optimizing their synthesis, and evaluating their efficacy in treating various diseases.'

tetrahydropyrimidinone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID74615
CHEMBL ID12593
SCHEMBL ID88886
MeSH IDM0492181

Synonyms (60)

Synonym
urea, 1,3-trimethylene-
einecs 217-443-2
ai3-50508
urea, n,n'-(1,3-propanediyl)-
perhydropyrimidin-2-one
nsc 21315
2-pyrimidinol, 3,4,5,6-tetrahydro-
tetrahydro-2(1h)-pyrimidinone
ec 217-443-2
unii-v5992lv6ag
v5992lv6ag ,
propylene urea
2-(1h)-tetrahydropyrimidinone
2-pyrimidinol,4,5,6-tetrahydro-
hexahydropyrimidin-2-one
nsc21315
hexahydro-2(1h)-pyrimidinone
urea,n'-(1,3-propanediyl)-
1852-17-1
urea,3-trimethylene-
2-ketohexahydropyrimidine
nsc-21315
pyrimidine, hexahydro-2-oxo-
propyleneurea
tetrahydropyrimidin-2(1h)-one
inchi=1/c4h8n2o/c7-4-5-2-1-3-6-4/h1-3h2,(h2,5,6,7
2(1h)-pyrimidinone, tetrahydro-
n,n'-trimethyleneurea, >=98.0%
CHEMBL12593
1,3-diazinan-2-one
tetrahydro-2-pyrimidone
tetrahydro-2-pyrimidinone
n,n'-trimethyleneurea
P0526
EN300-80795
A812933
AKOS006222798
3,4,5,6-tetrahydro-2(1h)-pyrimidinone
n,n'-propyleneurea
tetrahydro-pyrimidin-2-one
FT-0648303
SCHEMBL88886
3,4,5,6-tetrahydro-2-(1h)-pyrimidone
3,4,5,6-tetrahydro-2-(1h)-pyrimidinone
tetrahydropyrimidinone
1,3-diaza-cyclohexan-2-one
1,3-diaza-cyclohexane-2-one
AM90187
DTXSID9051820
W-107785
tetrahydro-2(1h)-pyrimidinone #
2(1h)-tetrahydropyrimidinone
mfcd00014593
3,4,5,6-tetrahydropyrimidin-2(1h)-one
SY051892
F14817
HR-0301
SB55523
CS-W023025
Z1203730774
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1570846Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019ACS medicinal chemistry letters, Oct-10, Volume: 10, Issue:10
A Bioreductive Prodrug of Cucurbitacin B Significantly Inhibits Tumor Growth in the 4T1 Xenograft Mice Model.
AID1570847Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019ACS medicinal chemistry letters, Oct-10, Volume: 10, Issue:10
A Bioreductive Prodrug of Cucurbitacin B Significantly Inhibits Tumor Growth in the 4T1 Xenograft Mice Model.
AID71775Percent of untreated control cell growth evaluated in friend leukemia cells on day 3 at a concentration of 4 mM1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Cyclic urea and thiourea derivatives as inducers of murine erythroleukemia differentiation.
AID71665Cell growth of friend erythroleukemia cells measured as percentage of control on day 6 at a concentration of 4 mM1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Cyclic urea and thiourea derivatives as inducers of murine erythroleukemia differentiation.
AID71654The degree of erythroid maturation was measured by assessing the proportion of benzidine-positive cells at a concentration of 4 mM1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Cyclic urea and thiourea derivatives as inducers of murine erythroleukemia differentiation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.69)18.7374
1990's0 (0.00)18.2507
2000's3 (23.08)29.6817
2010's8 (61.54)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.90 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.35 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]